FREmedica is collaborating with an exciting research project called Bringing Evidence to Alternative Medicine (BEAM).
BEAM is a mobile app that lets you visually track your progress and compare it to others on a similar care plan. Users will receive reminders to use your waveforce ONE, and optional motivational messages and tips on how to deal with chronic Lyme.
Data entered (in the form of simple multiple choice or numerical ranking) will be de-identified to protect privacy. FREmedica will then compare the data from waveforce ONE users against a control group of chronic Lyme sufferers who are not using the device. This will allow us to gather statistically valid data to show the outcomes and effectiveness of the waveforce ONE.
Sign up to get the latest on sales, new releases and more …
© 2018 FREmedica. All rights reserved.
Any statements made by FREmedica about waveforce ONE were developed based on extensive review of document number 1300013 that was issued on July 29, 2016 by the U.S. Department of Health and Human Services Food and Drug Administration.
This document, entitled General Wellness: Policy for Low Risk Devices - Guidance for Industry and Food and Drug Administration Staff, was issued to “provide clarity to industry and FDA staff on the Centre for Devices and Radiological Health’s (CDRH’s) compliance policy for low risk products that promote a healthy lifestyle (general wellness products)”.
The waveforce ONE by FREmedica Technologies Inc. does not profess to treat or cure any disease or illness. Always seek professional medical advice for the diagnosis and treatment of any health condition.